Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41433-024-03446-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
H syndrome with bilateral choroidal osteoma: Coincidence or association?
Eur J Ophthalmol
January 2025
Department of Medical Genetics, Istanbul Medipol University, Istanbul, Turkey.
Purpose: To report a case with bilateral corneal arcus and bilateral choroidal osteoma associated with H syndrome.
Methods: Descriptive case report.
Results: A 16-year-old girl with H syndrome was followed up in the pediatric nephrology clinic for chronic renal failure and was consulted to the ophthalmology clinic.
Clinical Features and Treatment Outcomes of Choroidal Osteoma in Asian Indians (80 Patients).
Retina
November 2024
Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.
Article Synopsis
- The study examined 80 Indian patients with choroidal osteoma, focusing on demographic and clinical characteristics as well as treatment outcomes.
- Most patients were female (61%), with the majority in their second decade of life; various associated complications like choroidal neovascularization (CNV) were noted in 40% of eyes.
- Treatment methods included anti-VEGF therapy for CNV and other procedures, with mean best corrected visual acuity improving slightly over a follow-up period, indicating the need for ongoing monitoring despite the generally benign nature of the condition.
Choroidal osteoma.
Eye (Lond)
November 2024
The Department of Ophthalmology, the First Affiliated Hospital of Anhui Medical University, HeFei, China.
Atypical Presentation of Choroidal Osteoma: Two Case Reports.
Int Med Case Rep J
November 2024
Ophthalmology Discipline, Centro Universitário Saúde ABC/ Faculdade de Medicina Do ABC, Santo André, Brasil.
Choroidal osteoma is a rare, benign, osseous choristoma presenting as an orange-yellow, well-defined fundus mass. It presents unilaterally in most cases, has a predilection for the female sex, and favor a juxtapapillary location, becoming clinically manifest when it involves the macula. Almost 60% of eyes with osteoma may suffer significant visual loss.
View Article and Find Full Text PDFInhibition of choroidal osteoma progression using bisphosphonate and RANKL-inhibitory treatment.
Am J Ophthalmol Case Rep
December 2024
Department of Ophthalmology, University of California, San Francisco, San Francisco, USA.
Purpose: To describe the use of anti-osteoclastic medications (i.e., bisphosphonates and receptor activator of nuclear factor kappa beta (RANK) ligand inhibitors) in treating choroidal osteoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!